BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 12905810)

  • 21. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference.
    Juonala M; Viikari JS; Hutri-Kähönen N; Pietikäinen M; Jokinen E; Taittonen L; Marniemi J; Rönnemaa T; Raitakari OT
    J Intern Med; 2004 Apr; 255(4):457-68. PubMed ID: 15049880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atheromatous risk factors among Thai labor forces by socioeconomic status.
    Narksawat K; Podhipak A; Punyaratabundhu P; Podang J
    J Med Assoc Thai; 2003 Jul; 86(7):655-65. PubMed ID: 12948261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of socioeconomic status with cardiovascular risk factors and lifestyle in a Mediterranean population.
    Schröder H; Rohlfs I; Schmelz EM; Marrugat J;
    Eur J Nutr; 2004 Apr; 43(2):77-85. PubMed ID: 15083314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cost-effectiveness analysis of Beijing Fangshan cardiovascular prevention program in 1992 - 1997].
    Huang G; Gu D; Wu X; Duan X; Xu X; Wu J; Xie B
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):78-80. PubMed ID: 11860903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Elderly population and campaigns for the prevention of hypercholesterolemia in Salamanca].
    Herrero Herrero JI; Martín Oterino JA; Sanz Ortega F; Mateos Sánchez A; Polo García JM; García Gómez ML; Pascual González F
    An Med Interna; 2001 Jan; 18(1):13-9. PubMed ID: 11387838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme.
    Sadeghi M; Roohafza HR; Kelishadi R
    Med J Malaysia; 2004 Oct; 59(4):460-7. PubMed ID: 15779578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment and analysis on the risk and community treatment of hypertension in rural areas in Changshu city].
    Xu MG; Sun GX; Zhou ZY; Li JQ; Yu RB; Gu DF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jan; 25(1):33-5. PubMed ID: 15061943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines?
    del Cañizo-Gómez FJ; Moreira-Andrés MN
    Diabetes Res Clin Pract; 2004 Aug; 65(2):125-33. PubMed ID: 15223224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of cardiovascular risk factors in obese children effects of inpatient and outpatient interventions.
    Reinehr T; de Sousa G; Wabitsch M
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):506-11. PubMed ID: 17033527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a community program for the control of cardiovascular risk factors: the CHAD program in Jerusalem.
    Abramson JH; Gofin R; Hopp C; Gofin J; Donchin M; Habib J
    Isr J Med Sci; 1981; 17(2-3):201-12. PubMed ID: 7228646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined influence of cardiorespiratory fitness and body mass index on cardiovascular disease risk factors among 8-18 year old youth: The Aerobics Center Longitudinal Study.
    Eisenmann JC; Welk GJ; Wickel EE; Blair SN
    Int J Pediatr Obes; 2007; 2(2):66-72. PubMed ID: 17763013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].
    Wang CH; Zhou X; Zhou GD; Han DF; Zheng F
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):554-8. PubMed ID: 15144588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a multicomponent workplace health promotion program conducted in Japan for improving employees' cardiovascular disease risk factors.
    Muto T; Yamauchi K
    Prev Med; 2001 Dec; 33(6):571-7. PubMed ID: 11716652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Longitudinal trends in major cardiovascular disease risk factors in the Czech population].
    Cífková R; Skodová Z
    Cas Lek Cesk; 2004; 143(4):219-26. PubMed ID: 15218719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hypertension in Lithuanian mariners.
    Kirkutis A; Norkiene S; Griciene P; Gricius J; Yang S; Gintautas J
    Proc West Pharmacol Soc; 2004; 47():71-5. PubMed ID: 15633617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a multicomponent worksite health promotion program for cardiovascular risk factors-correcting for the regression towards the mean effect.
    Prior JO; van Melle G; Crisinel A; Burnand B; Cornuz J; Darioli R
    Prev Med; 2005 Mar; 40(3):259-67. PubMed ID: 15533537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immigration, acculturation, and risk factors for obesity and cardiovascular disease: a comparison between Latinos of Peruvian descent in Peru and in the United States.
    Lizarzaburu JL; Palinkas LA
    Ethn Dis; 2002; 12(3):342-52. PubMed ID: 12148705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community screening for high blood pressure among adults in urban and rural Papua New Guinea.
    Benjamin AL
    P N G Med J; 2006; 49(3-4):137-46. PubMed ID: 18389971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.